Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Short term Debt (2016 - 2023)

Marimed (MRMD) has disclosed Short term Debt for 9 consecutive years, with $3.6 million as the latest value for Q3 2023.

  • On a quarterly basis, Short term Debt changed N/A to $3.6 million in Q3 2023 year-over-year; TTM through Sep 2023 was $3.6 million, a N/A change, with the full-year FY2020 number at $1.2 million, down 20.41% from a year prior.
  • Short term Debt was $3.6 million for Q3 2023 at Marimed, roughly flat from $3.6 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $3.6 million in Q2 2023 to a low of $77157.0 in Q2 2019.
  • A 3-year average of $1.6 million and a median of $1.2 million in 2020 define the central range for Short term Debt.
  • Peak YoY movement for Short term Debt: crashed 62.36% in 2019, then soared 1703.22% in 2020.
  • Marimed's Short term Debt stood at $1.5 million in 2019, then dropped by 20.41% to $1.2 million in 2020, then surged by 210.93% to $3.6 million in 2023.
  • Per Business Quant, the three most recent readings for MRMD's Short term Debt are $3.6 million (Q3 2023), $3.6 million (Q2 2023), and $3.3 million (Q1 2023).